ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets
February 24, 2019This year is already shaping up to be a big one for biopharma mergers and acquisitions, with Bristol-Myers Squibb’s planned $74 billion buyout of Celgene well underway. But analysts at Morningstar are predicting the BMS-Celgene deal will mark the beginnin
Pharma Sources Insight January 2025
